Skip to content-
Tempus Selected by University of Virginia As Partner for Large Granular Lymphocyte Leukemia Research Project
CHICAGO, Aug. 03, 2017 (GLOBE NEWSWIRE) — Tempus, a technology company focused on helping doctors personalize cancer care by collecting and integrating molecular and clinical data, and the University [...]
-
Tempus and Rush University Medical Center Partnering to Expand Hospital’s First Biobank
CHICAGO, July 21, 2017 (GLOBE NEWSWIRE) – Tempus, a technology company focused on helping doctors personalize cancer care by collecting, sorting and analyzing clinical and molecular data, and Rush [...]
-
Why Groupon’s cofounder is diving head first into healthcare
Very few people (myself included) can convincingly use the term “paradigm shift.” Eric Lefkofsky is one of the few who can. In 2017, he’s throwing the term on the table as he describes the [...]
-
Tempus to Assist University of California San Diego In Personalized Medicine Initiative
CHICAGO, July 06, 2017 (GLOBE NEWSWIRE) — Tempus, a technology company focused on helping doctors personalize cancer care by collecting, sorting and analyzing clinical and molecular data, will provide [...]
-
Eric Lefkofsky’s Self-Funded Mission to Cure Cancer Through Data
Eric Lefkofsky doesn’t like starting new companies. At least not at this stage in his career. The 47-year-old serial entrepreneur, along with his business partner Brad Keywell, has taken multiple [...]
-
Tempus and University of Michigan Collaborate on Breast Cancer Initiative
CHICAGO, June 08, 2017 (GLOBE NEWSWIRE) — Tempus, a technology company focused on helping doctors personalize cancer care by collecting, sorting and analyzing clinical and molecular data and the [...]
-
Death to Cancer, Byte by Byte
There has never been a more urgent time to harness and apply data science to help eradicate cancer. Why? For the first time, it is possible. We stand at the crossroads of two transformative advances [...]
-
Dr. Andrea Califano Joins Tempus Scientific Advisory Board and Tempus and DarwinHealth Partner on Research Initiative
CHICAGO, May 24, 2017 (GLOBE NEWSWIRE) — Dr. Andrea Califano, a pioneer in cancer systems biology and a renowned researcher at Columbia University, has joined the Tempus Scientific Advisory Board. In [...]
-
Getting Our Health Priorities in Order Panel: Prevention, Research, and Treatment @ Milken Institute Global Conference
-
Tempus and Northwestern Expand Partnership to Accelerate Personalized Medicine Efforts
Published in Yahoo! Finance – May 11, 2017 Tempus, a technology company focused on helping doctors personalize cancer care by collecting, sorting and analyzing clinical and molecular data and the [...]